ARK Investment Management’s UroGen Pharma URGN Stock Holding History

ARK Investment Management’s Portfolio URGN Stock Details URGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$2.28M	Sell	166,094 -19,696	-11%	-$270K	0.02%	132
2025 Q1	$2.05M	Buy	185,790 +45,642	+33%	+$505K	0.02%	132
2024 Q4	$1.49M	Buy	140,148 +18,514	+15%	+$197K	0.01%	153
2024 Q3	$1.54M	Sell	121,634 -30,147	-20%	-$383K	0.01%	153
2024 Q2	$2.55M	Buy	151,781 +5,452	+4%	+$91.5K	0.02%	134
2024 Q1	$2.19M	Sell	146,329 -15,196	-9%	-$228K	0.02%	183
2023 Q4	$2.42M	Sell	161,525 -53,747	-25%	-$806K	0.01%	154
2023 Q3	$3.02M	Buy	215,272 +13,354	+7%	+$187K	0.02%	140
2023 Q2	$2.09M	Sell	201,918 -68,828	-25%	-$712K	0.01%	171
2023 Q1	$2.5M	Buy	270,746 +73,808	+37%	+$682K	0.02%	152
2022 Q4	$1.75M	Sell	196,938 -84,763	-30%	-$752K	0.02%	200
2022 Q3	$2.34M	Sell	281,701 -20,423	-7%	-$170K	0.02%	163
2022 Q2	$1.61M	Sell	302,124 -31,348	-9%	-$167K	0.01%	220
2022 Q1	$2.91M	Buy	333,472 +146,979	+79%	+$1.28M	0.01%	179
2021 Q4	$1.77M	Sell	186,493 -57,672	-24%	-$549K	0.01%	247
2021 Q3	$4.11M	Sell	244,165 -72,083	-23%	-$1.21M	0.01%	195
2021 Q2	$4.83M	Buy	316,248 +24,378	+8%	+$372K	0.01%	242
2021 Q1	$5.69M	Buy	291,870 +218,101	+296%	+$4.25M	0.01%	208
2020 Q4	$1.33M	Buy	73,769 +39,557	+116%	+$713K	﹤0.01%	203
2020 Q3	$660K	Sell	34,212 -12,996	-28%	-$251K	﹤0.01%	180
2020 Q2	$1.23M	Buy	47,208 +30,387	+181%	+$794K	0.01%	141
2020 Q1	$300K	Buy	16,821 +796	+5%	+$14.2K	0.01%	158
2019 Q4	$535K	Buy	16,025 +1,790	+13%	+$59.8K	0.01%	129
2019 Q3	$339K	Buy	14,235 +706	+5%	+$16.8K	0.01%	179
2019 Q2	$486K	Buy	13,529 +4,522	+50%	+$162K	0.01%	136
2019 Q1	$333K	Sell	9,007 -2,291	-20%	-$84.7K	0.01%	160
2018 Q4	$486K	Buy	11,298 +40	+0.4%	+$1.72K	0.02%	112
2018 Q3	$532K	Buy	11,258 +1,820	+19%	+$86K	0.02%	139
2018 Q2	$470K	Sell	9,438 -4,064	-30%	-$202K	0.02%	146
2018 Q1	$671K	Buy	13,502 +4,218	+45%	+$210K	0.03%	111
2017 Q4	$345K	Buy	+9,284	New	+$345K	0.03%	118